Analysts See $-0.10 EPS for Xplore Technologies Corp. (XPLR); Bioptix (BIOP) Shorts Decreased By 10.56%

June 15, 2017 - By Hazel Jackson

Analysts expect Xplore Technologies Corp. (NASDAQ:XPLR) to report $-0.10 EPS on July, 5.They anticipate $0.01 EPS change or 11.11% from last quarter’s $-0.09 EPS. After having $0.02 EPS previously, Xplore Technologies Corp.’s analysts see -600.00% EPS growth. The stock decreased 4.12% or $0.08 on June 14, reaching $1.86. About shares traded. Xplore Technologies Corp. (NASDAQ:XPLR) has declined 39.81% since June 15, 2016 and is downtrending. It has underperformed by 56.51% the S&P500.

Bioptix Incorporated (NASDAQ:BIOP) had a decrease of 10.56% in short interest. BIOP’s SI was 14,400 shares in June as released by FINRA. Its down 10.56% from 16,100 shares previously. With 22,200 avg volume, 1 days are for Bioptix Incorporated (NASDAQ:BIOP)’s short sellers to cover BIOP’s short positions. The SI to Bioptix Incorporated’s float is 0.34%. The stock decreased 1.01% or $0.04 on June 14, reaching $3.91. About shares traded. Bioptix Inc (NASDAQ:BIOP) has declined 8.56% since June 15, 2016 and is downtrending. It has underperformed by 25.26% the S&P500.

Among 2 analysts covering Xplore Technologies Corp (NASDAQ:XPLR), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Xplore Technologies Corp had 4 analyst reports since July 13, 2016 according to SRatingsIntel. The stock of Xplore Technologies Corp. (NASDAQ:XPLR) has “Buy” rating given on Tuesday, September 13 by Maxim Group. The firm has “Neutral” rating by Roth Capital given on Wednesday, July 13. The company was maintained on Thursday, June 1 by Maxim Group. The firm earned “Hold” rating on Tuesday, May 30 by Roth Capital.

Xplore Technologies Corp. is engaged in the development, integration and marketing of rugged mobile personal computers (PCs). The company has market cap of $21.28 million. The Company’s rugged tablet PCs are designed to withstand various conditions, such as extreme temperatures, driving rain, repeated vibrations, dirt, dust and concussive shocks. It currently has negative earnings. Xplore’s products are used by a range of field personnel, including energy pipeline inspectors, public safety responders, warehouse workers and pharmaceutical scientists.

Bioptix, Inc., formerly Venaxis, Inc., provides Enhanced Surface Plasmon Resonance platform for the detection of molecular interactions. The company has market cap of $21.37 million. The Company’s line of Enhanced SPR instruments are designed to increase the flexibility and reliability of SPR. It currently has negative earnings. The Company’s SPR biosensors shed light on important binding parameters that are crucial for determining whether a biologic or small molecule drug will be efficacious in humans and at what dose a drug should be administered.